AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Market Snapshot
Headline Takeaway: Despite recent market outperformance (5.06% price rise),
News Highlights
Recent news items paint a mixed picture for the broader market, with limited direct impact on CCC Intelligent: U.S. vaccine policy changes suggest evolving healthcare dynamics, but no clear link to CCC’s business model. (May 29) Trump fast-tracks uranium mining in Utah, hinting at energy policy shifts, though broader commodities trends could indirectly affect industrial players. China’s factory activity showed slight improvement in May with a PMI of 49.5, still below the 50 threshold, indicating ongoing economic softness.
Analyst Views & Fundamentals

Analyst opinions are divergent, with one “Buy” and one “Neutral” rating from two institutions: Average (simple mean) rating score: 3.50 (Neutral) Weighted (performance-weighted) rating score: 2.48 (Underperform) Consistency: Analysts disagree, with one analyst from Barrington Research posting a poor historical win rate of 25% and a negative average return of -6.48%, while Barclays analyst Saket Kalia has a better 66.7% win rate and -1.82% average return.
Price trend vs. expectations: The stock has risen 5.06% recently, while the analyst-weighted expectations remain bearish, suggesting a disconnect between technical and fundamental perspectives.
Key fundamental factors and internal diagnostic scores (0-10):
Revenue-MV: Value = -0.89, Score = 2.00
Net profit attributable to parent company shareholders / Net profit (%): Value = 119.84%, Score = 3.00
Total operating revenue (YoY growth rate %): Value = 11.57%, Score = 2.00
Days sales outstanding: Value = 42.85 days, Score = 2.00
Profit-MV: Value = 0.48, Score = 2.00
Net income-Revenue: Value = -13.19%, Score = 2.00
PB-ROE: Value = 62.03%, Score = 3.00
Asset-MV: Value = -44.62%, Score = 0.00
Inventory turnover days: Value = 233.91 days, Score = 3.00
Cash-MV: Value = 11.85%, Score = 2.00
With a fundamental score of 5.73, the company shows moderate health, but key metrics like net income margins and asset utilization remain concerning.
Fund flows into CCC Intelligent show positive trends, particularly among larger investors:
Overall inflow ratio: 56.59%
Block (large) inflow ratio: 57.91%
Extra-large inflow ratio: 59.69%
This indicates strong interest from big money, with large and institutional investors showing more conviction than smaller retail players. However, the stock’s weak technicals raise questions about the sustainability of the recent price rise.
Technically, CCC Intelligent is in a danger zone, with a 1.0 internal diagnostic score (0-10). The technical indicators suggest the stock is in a weak trend with more bearish signals than bullish ones:
WR Overbought: Internal diagnostic score = 1.00. Historically, this indicator has delivered an average return of -1.65% and a win rate of just 33.33%.
WR Oversold: Internal diagnostic score = 1.00. With an average return of -2.55% and win rate of 28.57%, this also signals risk.
Recent chart patterns (last 5 days):
Dec 10: WR Oversold
Dec 11: Long Upper Shadow
Dec 12: WR Oversold
These signals suggest continued bearish pressure, and with only 2 bearish indicators against 0 bullish ones, the trend is clearly down.
Despite positive fund flows and moderate fundamental scores, the technical outlook for CCC Intelligent is weak, with an internal diagnostic score of just 1.0. This suggests high risk and poor momentum. The market may be overbought in the short term, and analysts remain divided.
Actionable takeaway: Investors should consider waiting for a pull-back before entering a position and closely monitor the next set of earnings and any changes in industry demand or regulatory trends.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.15 2025

Dec.15 2025

Dec.15 2025

Dec.15 2025

Dec.15 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet